Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
CONCLUSION: Our results show MP-MRI has moderate sensitivity (64%) and high specificity (94%) in detecting radio-recurrent intraprostatic disease, though disease tends to be under quantified and under staged. Greater emphasis on dynamic contrast images in overall scoring can improve diagnostic sensitivity.
ADVANCES IN KNOWLEDGE: MP-MRI tends to under quantify and under stage radio-recurrent prostate cancer. DCE has a potentially augmented role in detecting recurrent tumour compared with the de novo setting. This has relevance in the event of any future modified MP-MRI scoring system for the irradiated gland.
PMID: 33586998 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Kowa JY, Soneji N, Sohaib SA, Mayer E, Hazell S, Butterfield N, Shur J, Ap Dafydd D Tags: Br J Radiol Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | MRI Scan | PET Scan | Prostate Cancer | Prostatectomy | Radiology | Study | UK Health